Recombinant MS4A1 (Ocrelizumab Biosimilar) 抗体
This Mammalian Cells 单克隆 anti-MS4A1 (Ocrelizumab Biosimilar) antibody specifically detects MS4A1 (Ocrelizumab Biosimilar) in ELISA. The antibody is reactive with 人 samples.
产品编号 ABIN7487883
发货至:
中国
Contact our Customer Service for availability and price in your country.
Contact Info
Our Local Distributor
中国
北京 101111
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
Quick Overview for Recombinant MS4A1 (Ocrelizumab Biosimilar) 抗体 (ABIN7487883)
抗原
MS4A1 (Ocrelizumab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Mammalian Cells
克隆类型
单克隆
标记
This MS4A1 (Ocrelizumab Biosimilar) antibody is un-conjugated
应用范围
ELISA
质量等级
Research Grade
-
-
Expression System
- Mammalian cells
-
原理
- Ocrelizumab Biosimilar - Anti-MS4A1, CD20 mAb
-
产品特性
- Antibody Type: IgG1-nd
-
纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
-
亚型
- IgG1
-
-
-
-
限制
- 仅限研究用
-
-
-
缓冲液
- PBS pH 7.5
-
储存条件
- -80 °C
-
储存方法
- store at -80°C
-
-
- MS4A1 (Ocrelizumab Biosimilar)
-
物质类
- Biosimilar
-
背景
-
2H7
Ocrelizumab is a CD20-directed cytolytic antibody, which is suitable for the treatment of patients with relapsed or primary progressive multiple sclerosis. It is a second-generation recombinant humanized monoclonal antibody of isotype IgG1 that can selectively target B lymphocytes expressing CD20 antigen. Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous system, which can cause neurological dysfunction. Most patients with MS experience recurrent episodes with functional deterioration, followed by recovery or remission. -
CAS-编号
- 637334-45-3
抗原
-
You are here:
